NCT05355948View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke

NACompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2024

Conditions
Atrial Fibrillation/Flutter in Patients With High Risk of Stroke
Interventions
DEVICE

MEMO Patch PLUS for 1 day

Individuals randomized to one-day monitoring will wear MEMO Patch PLUS for 1 day. After that, confirm the monitoring result and carry out a fixed schedule.

DEVICE

MEMO Patch PLUS for More than 8-days

Individuals randomized to More than 8-days monitoring will wear MEMO Patch PLUS for 8 days \~ 14 days at their voluntarily. After that, confirm the monitoring result and carry out a fixed schedule.

Trial Locations (1)

Unknown

Yonsei University Health System, Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER